Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 5.24612803 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.24612803 |
3 | alpha-linolenic acid metabolic process (GO:0036109) | 5.21233469 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.93978292 |
5 | L-phenylalanine metabolic process (GO:0006558) | 4.93978292 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.66926084 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 4.35098488 |
8 | negative regulation of fibrinolysis (GO:0051918) | 4.34478323 |
9 | complement activation, alternative pathway (GO:0006957) | 4.14666915 |
10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.12258527 |
11 | protein carboxylation (GO:0018214) | 4.12258527 |
12 | regulation of protein activation cascade (GO:2000257) | 4.10759246 |
13 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.09031871 |
14 | bile acid biosynthetic process (GO:0006699) | 4.08813603 |
15 | regulation of fibrinolysis (GO:0051917) | 3.98479184 |
16 | regulation of complement activation (GO:0030449) | 3.92194889 |
17 | glyoxylate metabolic process (GO:0046487) | 3.92112606 |
18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.91345045 |
19 | kynurenine metabolic process (GO:0070189) | 3.85772451 |
20 | sulfur amino acid catabolic process (GO:0000098) | 3.85729970 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 3.68972126 |
22 | protein heterotrimerization (GO:0070208) | 3.68824298 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.65818641 |
24 | urea cycle (GO:0000050) | 3.62055664 |
25 | urea metabolic process (GO:0019627) | 3.62055664 |
26 | indole-containing compound catabolic process (GO:0042436) | 3.56046122 |
27 | indolalkylamine catabolic process (GO:0046218) | 3.56046122 |
28 | tryptophan catabolic process (GO:0006569) | 3.56046122 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 3.55703400 |
30 | lysine metabolic process (GO:0006553) | 3.53959616 |
31 | lysine catabolic process (GO:0006554) | 3.53959616 |
32 | cellular potassium ion homeostasis (GO:0030007) | 3.53421163 |
33 | positive regulation of fatty acid oxidation (GO:0046321) | 3.52887086 |
34 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50379002 |
35 | extracellular matrix assembly (GO:0085029) | 3.48266134 |
36 | plasma lipoprotein particle clearance (GO:0034381) | 3.47464312 |
37 | dermatan sulfate biosynthetic process (GO:0030208) | 3.47073293 |
38 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.43864455 |
39 | bile acid metabolic process (GO:0008206) | 3.43181785 |
40 | positive regulation of lipid catabolic process (GO:0050996) | 3.42177192 |
41 | reverse cholesterol transport (GO:0043691) | 3.39371244 |
42 | central nervous system myelination (GO:0022010) | 3.39303379 |
43 | axon ensheathment in central nervous system (GO:0032291) | 3.39303379 |
44 | glutamate metabolic process (GO:0006536) | 3.39056030 |
45 | dermatan sulfate metabolic process (GO:0030205) | 3.38111542 |
46 | regulation of cholesterol esterification (GO:0010872) | 3.35850556 |
47 | tryptophan metabolic process (GO:0006568) | 3.35317149 |
48 | cysteine metabolic process (GO:0006534) | 3.33714415 |
49 | coenzyme catabolic process (GO:0009109) | 3.33306352 |
50 | sodium ion export (GO:0071436) | 3.33183827 |
51 | epoxygenase P450 pathway (GO:0019373) | 3.33147002 |
52 | cell migration involved in heart development (GO:0060973) | 3.32004287 |
53 | protein-lipid complex remodeling (GO:0034368) | 3.28780457 |
54 | macromolecular complex remodeling (GO:0034367) | 3.28780457 |
55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.28780457 |
56 | nitrogen cycle metabolic process (GO:0071941) | 3.26557501 |
57 | cellular modified amino acid catabolic process (GO:0042219) | 3.26536382 |
58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25280342 |
59 | acylglycerol homeostasis (GO:0055090) | 3.23463481 |
60 | triglyceride homeostasis (GO:0070328) | 3.23463481 |
61 | alpha-amino acid catabolic process (GO:1901606) | 3.22134742 |
62 | regulation of cholesterol homeostasis (GO:2000188) | 3.19999984 |
63 | homocysteine metabolic process (GO:0050667) | 3.17574128 |
64 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.17468564 |
65 | cellular ketone body metabolic process (GO:0046950) | 3.14992657 |
66 | amino-acid betaine metabolic process (GO:0006577) | 3.14915426 |
67 | serine family amino acid catabolic process (GO:0009071) | 3.14589505 |
68 | negative regulation of protein activation cascade (GO:2000258) | 3.11665537 |
69 | tyrosine metabolic process (GO:0006570) | 3.11656099 |
70 | acetyl-CoA metabolic process (GO:0006084) | 3.10502017 |
71 | chondroitin sulfate catabolic process (GO:0030207) | 3.09257742 |
72 | cellular amino acid catabolic process (GO:0009063) | 3.08030933 |
73 | regulation of plasminogen activation (GO:0010755) | 3.05843769 |
74 | negative regulation of sterol transport (GO:0032372) | 3.04302262 |
75 | negative regulation of cholesterol transport (GO:0032375) | 3.04302262 |
76 | extracellular fibril organization (GO:0043206) | 3.01867516 |
77 | ethanol oxidation (GO:0006069) | 3.00838779 |
78 | phospholipid efflux (GO:0033700) | 3.00607135 |
79 | aspartate family amino acid catabolic process (GO:0009068) | 2.99731837 |
80 | collagen fibril organization (GO:0030199) | 2.97862306 |
81 | short-chain fatty acid metabolic process (GO:0046459) | 2.97583633 |
82 | phospholipid homeostasis (GO:0055091) | 2.96263784 |
83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.95631915 |
84 | aromatic amino acid family metabolic process (GO:0009072) | 2.95260456 |
85 | cell communication by electrical coupling (GO:0010644) | 2.94931502 |
86 | fibrinolysis (GO:0042730) | 2.94533058 |
87 | postsynaptic membrane organization (GO:0001941) | 2.93553151 |
88 | glutamate secretion (GO:0014047) | 2.90097061 |
89 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89415082 |
90 | cholesterol efflux (GO:0033344) | 2.87841075 |
91 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.87326804 |
92 | peripheral nervous system axon ensheathment (GO:0032292) | 2.86454706 |
93 | myelination in peripheral nervous system (GO:0022011) | 2.86454706 |
94 | dicarboxylic acid catabolic process (GO:0043649) | 2.85823577 |
95 | barbed-end actin filament capping (GO:0051016) | 2.85715141 |
96 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85509354 |
97 | cardiac myofibril assembly (GO:0055003) | 2.84909607 |
98 | fatty acid transmembrane transport (GO:1902001) | 2.84649474 |
99 | regulation of fatty acid oxidation (GO:0046320) | 2.84311299 |
100 | fatty acid beta-oxidation (GO:0006635) | 2.83961384 |
101 | cellular glucuronidation (GO:0052695) | 2.83802633 |
102 | negative regulation of lipase activity (GO:0060192) | 2.83078350 |
103 | very long-chain fatty acid metabolic process (GO:0000038) | 2.82745850 |
104 | protein-lipid complex assembly (GO:0065005) | 2.81804065 |
105 | linoleic acid metabolic process (GO:0043651) | 2.81050507 |
106 | low-density lipoprotein particle remodeling (GO:0034374) | 2.80561380 |
107 | cGMP-mediated signaling (GO:0019934) | 2.79524299 |
108 | amino acid import (GO:0043090) | 2.76521958 |
109 | metanephric mesenchyme development (GO:0072075) | 2.75888263 |
110 | complement activation (GO:0006956) | 2.75455819 |
111 | fatty acid oxidation (GO:0019395) | 2.73885225 |
112 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.73820596 |
113 | plasma lipoprotein particle assembly (GO:0034377) | 2.73625109 |
114 | kidney mesenchyme development (GO:0072074) | 2.73589070 |
115 | opsonization (GO:0008228) | 2.73253252 |
116 | L-amino acid import (GO:0043092) | 2.72622849 |
117 | regulation of cholesterol metabolic process (GO:0090181) | 2.71788568 |
118 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.71613909 |
119 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.71587228 |
120 | astrocyte differentiation (GO:0048708) | 2.71241155 |
121 | lipid oxidation (GO:0034440) | 2.70866039 |
122 | monocarboxylic acid catabolic process (GO:0072329) | 2.70764469 |
123 | cholesterol homeostasis (GO:0042632) | 2.70215212 |
124 | carboxylic acid catabolic process (GO:0046395) | 2.70102558 |
125 | organic acid catabolic process (GO:0016054) | 2.70102558 |
126 | arginine metabolic process (GO:0006525) | 2.68579861 |
127 | ketone body metabolic process (GO:1902224) | 2.68378605 |
128 | locomotory exploration behavior (GO:0035641) | 2.67809211 |
129 | fatty acid catabolic process (GO:0009062) | 2.67322152 |
130 | sterol homeostasis (GO:0055092) | 2.66995568 |
131 | cerebellar granule cell differentiation (GO:0021707) | 2.65843451 |
132 | midgut development (GO:0007494) | 2.64285813 |
133 | acylglycerol catabolic process (GO:0046464) | 2.63684967 |
134 | synaptic vesicle maturation (GO:0016188) | 2.63238993 |
135 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.62421047 |
136 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.62395050 |
137 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.61203610 |
138 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.58548940 |
139 | myofibril assembly (GO:0030239) | 2.57222214 |
140 | astrocyte development (GO:0014002) | 2.56969872 |
141 | potassium ion homeostasis (GO:0055075) | 2.55044172 |
142 | cellular response to epinephrine stimulus (GO:0071872) | 2.54292066 |
143 | negative regulation of catenin import into nucleus (GO:0035414) | 2.53327797 |
144 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.52946139 |
145 | chondrocyte proliferation (GO:0035988) | 2.51064955 |
146 | fibril organization (GO:0097435) | 2.50878421 |
147 | activation of protein kinase A activity (GO:0034199) | 2.45078959 |
148 | muscle filament sliding (GO:0030049) | 2.43311126 |
149 | actin-myosin filament sliding (GO:0033275) | 2.43311126 |
150 | negative regulation of protein localization to cell surface (GO:2000009) | 2.42778290 |
151 | neuronal ion channel clustering (GO:0045161) | 2.40347418 |
152 | protein targeting to plasma membrane (GO:0072661) | 2.39744075 |
153 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.39234489 |
154 | potassium ion import (GO:0010107) | 2.38876428 |
155 | endodermal cell differentiation (GO:0035987) | 2.38758046 |
156 | basement membrane organization (GO:0071711) | 2.37778892 |
157 | cellular response to monoamine stimulus (GO:0071868) | 2.37210912 |
158 | cellular response to catecholamine stimulus (GO:0071870) | 2.37210912 |
159 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.36233267 |
160 | type B pancreatic cell proliferation (GO:0044342) | 2.35916640 |
161 | adherens junction assembly (GO:0034333) | 2.34916736 |
162 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.34760918 |
163 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.34379540 |
164 | adhesion of symbiont to host cell (GO:0044650) | 2.33907655 |
165 | virion attachment to host cell (GO:0019062) | 2.33907655 |
166 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.31738870 |
167 | positive regulation of osteoblast proliferation (GO:0033690) | 2.31388035 |
168 | synaptic vesicle exocytosis (GO:0016079) | 2.31290778 |
169 | cortical actin cytoskeleton organization (GO:0030866) | 2.31036675 |
170 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.29091150 |
171 | ensheathment of neurons (GO:0007272) | 2.27500327 |
172 | axon ensheathment (GO:0008366) | 2.27500327 |
173 | apoptotic cell clearance (GO:0043277) | 2.26308763 |
174 | focal adhesion assembly (GO:0048041) | 2.25509587 |
175 | cell-substrate adherens junction assembly (GO:0007045) | 2.25509587 |
176 | stress fiber assembly (GO:0043149) | 2.23609918 |
177 | import into cell (GO:0098657) | 2.23059027 |
178 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.22655277 |
179 | positive regulation of fibroblast migration (GO:0010763) | 2.22612067 |
180 | regulation of the force of heart contraction (GO:0002026) | 2.22154458 |
181 | myelination (GO:0042552) | 2.21768714 |
182 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.20471782 |
183 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.20293605 |
184 | neuromuscular process controlling balance (GO:0050885) | 2.20213629 |
185 | membrane assembly (GO:0071709) | 2.19605992 |
186 | regulation of extracellular matrix disassembly (GO:0010715) | 2.19022126 |
187 | actin-mediated cell contraction (GO:0070252) | 2.19008459 |
188 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.18623926 |
189 | axon extension involved in axon guidance (GO:0048846) | 2.18623926 |
190 | cardiac muscle hypertrophy (GO:0003300) | 2.17063650 |
191 | positive regulation of extracellular matrix organization (GO:1903055) | 2.17006217 |
192 | bone trabecula formation (GO:0060346) | 2.16956305 |
193 | positive regulation of receptor recycling (GO:0001921) | 2.16617117 |
194 | cortical cytoskeleton organization (GO:0030865) | 2.16090800 |
195 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.16012893 |
196 | cell volume homeostasis (GO:0006884) | 2.15076130 |
197 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.15028251 |
198 | muscle hypertrophy in response to stress (GO:0003299) | 2.15028251 |
199 | cardiac muscle adaptation (GO:0014887) | 2.15028251 |
200 | cardiac muscle contraction (GO:0060048) | 2.14753948 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.64070911 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66811983 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.29988638 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93284688 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.90177085 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87359804 |
7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.86047647 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.70456559 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45918650 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15136299 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06998766 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93105486 |
13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.91244650 |
14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.82256358 |
15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67201198 |
16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66782110 |
17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60537180 |
18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.57172001 |
19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.57172001 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53321015 |
21 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51582762 |
22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36933397 |
23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36637683 |
24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.36385826 |
25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36262086 |
26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36149862 |
27 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34327720 |
28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34327720 |
29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34274060 |
30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33658442 |
31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33644583 |
32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32031250 |
33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31964355 |
34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30539886 |
35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27600319 |
36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.26687773 |
37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25378021 |
38 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.24166133 |
39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22766601 |
40 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22437684 |
41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21217083 |
42 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18563405 |
43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.18485518 |
44 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.16372242 |
45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16050325 |
46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15671917 |
47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15254237 |
48 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14754334 |
49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14535971 |
50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11225225 |
51 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.10734265 |
52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10699250 |
53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10310321 |
54 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09709869 |
55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08913567 |
56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08860150 |
57 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08675650 |
58 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08087023 |
59 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08087023 |
60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07953392 |
61 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07641495 |
62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07520101 |
63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.06921556 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06250483 |
65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05099617 |
66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04231107 |
67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.03936540 |
68 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02140192 |
69 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.01749034 |
70 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01379559 |
71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01238285 |
72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.01128423 |
73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00801889 |
74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99595940 |
75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99241092 |
76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97533192 |
77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97259489 |
78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97114247 |
79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96850470 |
80 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96734168 |
81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95275129 |
82 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.94930735 |
83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.94295863 |
84 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.93662994 |
85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93457620 |
86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93092631 |
87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92247118 |
88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91553992 |
89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90453702 |
90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90356490 |
91 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.90299292 |
92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89470259 |
93 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88495210 |
94 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.88485479 |
95 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.87820082 |
96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87566832 |
97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85798988 |
98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85289300 |
99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85283184 |
100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.85112664 |
101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84307457 |
102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83812931 |
103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83593250 |
104 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83571554 |
105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83253683 |
106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.83207636 |
107 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82426695 |
108 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82338612 |
109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82023385 |
110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81203003 |
111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80914204 |
112 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.80749646 |
113 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80433107 |
114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79574617 |
115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78654119 |
116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77112517 |
117 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76651599 |
118 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76435211 |
119 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76382726 |
120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76242020 |
121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76130556 |
122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.75189004 |
123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.75155174 |
124 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.75113532 |
125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74940172 |
126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74455994 |
127 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74097504 |
128 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.73808680 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.45638274 |
2 | MP0005360_urolithiasis | 5.13625253 |
3 | MP0008438_abnormal_cutaneous_collagen | 4.31892866 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.98845448 |
5 | MP0005365_abnormal_bile_salt | 3.84357525 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.31193263 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11967226 |
8 | MP0003252_abnormal_bile_duct | 2.95008463 |
9 | MP0010329_abnormal_lipoprotein_level | 2.74102963 |
10 | MP0009840_abnormal_foam_cell | 2.46148087 |
11 | MP0005275_abnormal_skin_tensile | 2.33917812 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.33788303 |
13 | MP0005503_abnormal_tendon_morphology | 2.14370954 |
14 | MP0005083_abnormal_biliary_tract | 1.93686446 |
15 | MP0004130_abnormal_muscle_cell | 1.93223845 |
16 | MP0005332_abnormal_amino_acid | 1.92302693 |
17 | MP0003195_calcinosis | 1.84196442 |
18 | MP0003279_aneurysm | 1.81939545 |
19 | MP0003191_abnormal_cellular_cholesterol | 1.78105127 |
20 | MP0002118_abnormal_lipid_homeostasis | 1.77988855 |
21 | MP0002837_dystrophic_cardiac_calcinosis | 1.71838679 |
22 | MP0003690_abnormal_glial_cell | 1.71457591 |
23 | MP0009384_cardiac_valve_regurgitation | 1.67191231 |
24 | MP0010368_abnormal_lymphatic_system | 1.63575895 |
25 | MP0004270_analgesia | 1.62466320 |
26 | MP0004272_abnormal_basement_membrane | 1.60467020 |
27 | MP0005670_abnormal_white_adipose | 1.57193046 |
28 | MP0005257_abnormal_intraocular_pressure | 1.55422962 |
29 | MP0000751_myopathy | 1.55330866 |
30 | MP0001958_emphysema | 1.54675293 |
31 | MP0005623_abnormal_meninges_morphology | 1.46457067 |
32 | MP0003635_abnormal_synaptic_transmissio | 1.43462767 |
33 | MP0005423_abnormal_somatic_nervous | 1.41815095 |
34 | MP0000609_abnormal_liver_physiology | 1.39037313 |
35 | MP0001666_abnormal_nutrient_absorption | 1.36369279 |
36 | MP0003329_amyloid_beta_deposits | 1.28200555 |
37 | MP0002108_abnormal_muscle_morphology | 1.27530472 |
38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27225742 |
39 | MP0003566_abnormal_cell_adhesion | 1.26649486 |
40 | MP0005171_absent_coat_pigmentation | 1.25340287 |
41 | MP0005666_abnormal_adipose_tissue | 1.25295600 |
42 | MP0008569_lethality_at_weaning | 1.24102844 |
43 | MP0001542_abnormal_bone_strength | 1.18217441 |
44 | MP0009780_abnormal_chondrocyte_physiolo | 1.17986188 |
45 | MP0000604_amyloidosis | 1.17732616 |
46 | MP0003879_abnormal_hair_cell | 1.16903125 |
47 | MP0002064_seizures | 1.15770129 |
48 | MP0002971_abnormal_brown_adipose | 1.15714019 |
49 | MP0000920_abnormal_myelination | 1.13155398 |
50 | MP0005319_abnormal_enzyme/_coenzyme | 1.08587850 |
51 | MP0002063_abnormal_learning/memory/cond | 1.05426310 |
52 | MP0003880_abnormal_central_pattern | 1.05035975 |
53 | MP0004185_abnormal_adipocyte_glucose | 1.04872620 |
54 | MP0000747_muscle_weakness | 1.04434742 |
55 | MP0004087_abnormal_muscle_fiber | 1.04119167 |
56 | MP0005375_adipose_tissue_phenotype | 1.03980251 |
57 | MP0001486_abnormal_startle_reflex | 1.01558839 |
58 | MP0002972_abnormal_cardiac_muscle | 0.99618365 |
59 | MP0005388_respiratory_system_phenotype | 0.98235167 |
60 | MP0002133_abnormal_respiratory_system | 0.98235167 |
61 | MP0000733_abnormal_muscle_development | 0.97941486 |
62 | MP0002734_abnormal_mechanical_nocicepti | 0.96969612 |
63 | MP0002106_abnormal_muscle_physiology | 0.96032488 |
64 | MP0002249_abnormal_larynx_morphology | 0.95854525 |
65 | MP0006138_congestive_heart_failure | 0.95299853 |
66 | MP0004858_abnormal_nervous_system | 0.95215839 |
67 | MP0002272_abnormal_nervous_system | 0.95173132 |
68 | MP0003868_abnormal_feces_composition | 0.94885367 |
69 | MP0002295_abnormal_pulmonary_circulatio | 0.94828759 |
70 | MP0000013_abnormal_adipose_tissue | 0.94106042 |
71 | MP0005409_darkened_coat_color | 0.94077281 |
72 | MP0005167_abnormal_blood-brain_barrier | 0.93103892 |
73 | MP0004510_myositis | 0.93013442 |
74 | MP0010030_abnormal_orbit_morphology | 0.92710860 |
75 | MP0000003_abnormal_adipose_tissue | 0.92566428 |
76 | MP0003828_pulmonary_edema | 0.91211504 |
77 | MP0000749_muscle_degeneration | 0.90952641 |
78 | MP0005330_cardiomyopathy | 0.90527044 |
79 | MP0002060_abnormal_skin_morphology | 0.90428120 |
80 | MP0002168_other_aberrant_phenotype | 0.89772794 |
81 | MP0001502_abnormal_circadian_rhythm | 0.89568891 |
82 | MP0004019_abnormal_vitamin_homeostasis | 0.89288398 |
83 | MP0002269_muscular_atrophy | 0.87602869 |
84 | MP0004215_abnormal_myocardial_fiber | 0.87037299 |
85 | MP0001348_abnormal_lacrimal_gland | 0.86577026 |
86 | MP0004145_abnormal_muscle_electrophysio | 0.86572127 |
87 | MP0003950_abnormal_plasma_membrane | 0.86363824 |
88 | MP0000759_abnormal_skeletal_muscle | 0.83673620 |
89 | MP0006054_spinal_hemorrhage | 0.82256947 |
90 | MP0003075_altered_response_to | 0.82231813 |
91 | MP0005595_abnormal_vascular_smooth | 0.81386554 |
92 | MP0004036_abnormal_muscle_relaxation | 0.79634090 |
93 | MP0000767_abnormal_smooth_muscle | 0.79103964 |
94 | MP0000762_abnormal_tongue_morphology | 0.78718251 |
95 | MP0003091_abnormal_cell_migration | 0.78680166 |
96 | MP0001177_atelectasis | 0.78505347 |
97 | MP0005165_increased_susceptibility_to | 0.77823115 |
98 | MP0005508_abnormal_skeleton_morphology | 0.77181089 |
99 | MP0000163_abnormal_cartilage_morphology | 0.76256834 |
100 | MP0003942_abnormal_urinary_system | 0.75159626 |
101 | MP0002896_abnormal_bone_mineralization | 0.74799450 |
102 | MP0009053_abnormal_anal_canal | 0.73899476 |
103 | MP0009745_abnormal_behavioral_response | 0.73560084 |
104 | MP0009250_abnormal_appendicular_skeleto | 0.73088698 |
105 | MP0005334_abnormal_fat_pad | 0.73065819 |
106 | MP0003385_abnormal_body_wall | 0.72812042 |
107 | MP0005620_abnormal_muscle_contractility | 0.72290070 |
108 | MP0005023_abnormal_wound_healing | 0.71863372 |
109 | MP0004883_abnormal_blood_vessel | 0.71859984 |
110 | MP0001879_abnormal_lymphatic_vessel | 0.71620914 |
111 | MP0000428_abnormal_craniofacial_morphol | 0.71074116 |
112 | MP0001299_abnormal_eye_distance/ | 0.69905464 |
113 | MP0002128_abnormal_blood_circulation | 0.68876138 |
114 | MP0002115_abnormal_skeleton_extremities | 0.68754621 |
115 | MP0002254_reproductive_system_inflammat | 0.68066759 |
116 | MP0005248_abnormal_Harderian_gland | 0.67851103 |
117 | MP0000598_abnormal_liver_morphology | 0.67573971 |
118 | MP0003045_fibrosis | 0.67006461 |
119 | MP0003011_delayed_dark_adaptation | 0.65229758 |
120 | MP0005164_abnormal_response_to | 0.64681998 |
121 | MP0004084_abnormal_cardiac_muscle | 0.64548698 |
122 | MP0004885_abnormal_endolymph | 0.64506442 |
123 | MP0005647_abnormal_sex_gland | 0.64447731 |
124 | MP0000534_abnormal_ureter_morphology | 0.63981068 |
125 | MP0003115_abnormal_respiratory_system | 0.63871212 |
126 | MP0003633_abnormal_nervous_system | 0.63688533 |
127 | MP0003656_abnormal_erythrocyte_physiolo | 0.63683897 |
128 | MP0010630_abnormal_cardiac_muscle | 0.63672091 |
129 | MP0000639_abnormal_adrenal_gland | 0.63561426 |
130 | MP0005369_muscle_phenotype | 0.63201132 |
131 | MP0000750_abnormal_muscle_regeneration | 0.62770356 |
132 | MP0004859_abnormal_synaptic_plasticity | 0.61386726 |
133 | MP0003634_abnormal_glial_cell | 0.61235075 |
134 | MP0001544_abnormal_cardiovascular_syste | 0.61134443 |
135 | MP0005385_cardiovascular_system_phenoty | 0.61134443 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.79535882 |
2 | Xanthomatosis (HP:0000991) | 4.62109146 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.38068887 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.26940744 |
5 | Complement deficiency (HP:0004431) | 4.24101455 |
6 | Hyperlipoproteinemia (HP:0010980) | 4.16401294 |
7 | Protrusio acetabuli (HP:0003179) | 4.04491628 |
8 | Premature rupture of membranes (HP:0001788) | 3.72672330 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.67719889 |
10 | Vascular tortuosity (HP:0004948) | 3.63981816 |
11 | Hypoalphalipoproteinemia (HP:0003233) | 3.59235191 |
12 | Broad metatarsal (HP:0001783) | 3.53989404 |
13 | Prolonged partial thromboplastin time (HP:0003645) | 3.52324513 |
14 | Hypobetalipoproteinemia (HP:0003563) | 3.44301835 |
15 | Epidermoid cyst (HP:0200040) | 3.29638022 |
16 | Hypolipoproteinemia (HP:0010981) | 3.28349057 |
17 | Arterial tortuosity (HP:0005116) | 3.18659518 |
18 | Hyperammonemia (HP:0001987) | 3.14870113 |
19 | Obstructive sleep apnea (HP:0002870) | 3.09033558 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.07373462 |
21 | Abnormality of complement system (HP:0005339) | 3.04964046 |
22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00369682 |
23 | Ketosis (HP:0001946) | 2.99677862 |
24 | Shallow orbits (HP:0000586) | 2.93512157 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87772220 |
26 | Abnormality of glycine metabolism (HP:0010895) | 2.87772220 |
27 | Type 1 muscle fiber predominance (HP:0003803) | 2.81716450 |
28 | Hyperglycinemia (HP:0002154) | 2.80587076 |
29 | Myocardial infarction (HP:0001658) | 2.77970887 |
30 | Peritonitis (HP:0002586) | 2.75949420 |
31 | Wormian bones (HP:0002645) | 2.73636457 |
32 | Turricephaly (HP:0000262) | 2.73212848 |
33 | Vertebral compression fractures (HP:0002953) | 2.68000053 |
34 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.63525072 |
35 | Neonatal short-limb short stature (HP:0008921) | 2.63052216 |
36 | Skin nodule (HP:0200036) | 2.62512296 |
37 | Mitral regurgitation (HP:0001653) | 2.62273718 |
38 | Mitral stenosis (HP:0001718) | 2.60261280 |
39 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.59021648 |
40 | Hyperglycinuria (HP:0003108) | 2.56644328 |
41 | Muscle fiber inclusion bodies (HP:0100299) | 2.55615232 |
42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.54373582 |
43 | Hypoglycemic coma (HP:0001325) | 2.52800602 |
44 | Fragile skin (HP:0001030) | 2.52227382 |
45 | Joint hemorrhage (HP:0005261) | 2.52140512 |
46 | Nemaline bodies (HP:0003798) | 2.50515908 |
47 | Abnormality of the Achilles tendon (HP:0005109) | 2.45002006 |
48 | Hypercholesterolemia (HP:0003124) | 2.43543931 |
49 | Atrophic scars (HP:0001075) | 2.43254658 |
50 | Aortic dissection (HP:0002647) | 2.38779399 |
51 | Bowel diverticulosis (HP:0005222) | 2.38571623 |
52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.37865698 |
53 | Ankle contracture (HP:0006466) | 2.32862975 |
54 | Cervical subluxation (HP:0003308) | 2.32065075 |
55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.31814213 |
56 | Cerebral aneurysm (HP:0004944) | 2.31349179 |
57 | Mitral valve prolapse (HP:0001634) | 2.24888263 |
58 | Exercise-induced myalgia (HP:0003738) | 2.22519269 |
59 | Abnormality of methionine metabolism (HP:0010901) | 2.22115464 |
60 | Bundle branch block (HP:0011710) | 2.22046182 |
61 | Delayed CNS myelination (HP:0002188) | 2.21579759 |
62 | Hyporeflexia of lower limbs (HP:0002600) | 2.21541101 |
63 | Ketoacidosis (HP:0001993) | 2.21001658 |
64 | Coronal craniosynostosis (HP:0004440) | 2.20357779 |
65 | Infantile muscular hypotonia (HP:0008947) | 2.19503246 |
66 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18427639 |
67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.18156835 |
68 | Distal lower limb muscle weakness (HP:0009053) | 2.16922936 |
69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15776345 |
70 | Increased connective tissue (HP:0009025) | 2.14638017 |
71 | Hypoplasia of the iris (HP:0007676) | 2.14562426 |
72 | Genu recurvatum (HP:0002816) | 2.11692287 |
73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11092393 |
74 | Hypoventilation (HP:0002791) | 2.08693615 |
75 | Abnormality of dentin (HP:0010299) | 2.08455652 |
76 | Bladder diverticulum (HP:0000015) | 2.06640818 |
77 | Cardiovascular calcification (HP:0011915) | 2.05429660 |
78 | Achilles tendon contracture (HP:0001771) | 2.05035067 |
79 | Fat malabsorption (HP:0002630) | 2.04050023 |
80 | Ulnar bowing (HP:0003031) | 2.02053359 |
81 | Myoglobinuria (HP:0002913) | 2.01292893 |
82 | Neurofibrillary tangles (HP:0002185) | 2.01127562 |
83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.01050785 |
84 | Amyloidosis (HP:0011034) | 2.00355625 |
85 | Systemic lupus erythematosus (HP:0002725) | 1.98783237 |
86 | Limited hip movement (HP:0008800) | 1.98736338 |
87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98681796 |
88 | Neck muscle weakness (HP:0000467) | 1.98148637 |
89 | EMG: myopathic abnormalities (HP:0003458) | 1.96555400 |
90 | Difficulty running (HP:0009046) | 1.95653958 |
91 | Asymmetric septal hypertrophy (HP:0001670) | 1.95292747 |
92 | Aortic regurgitation (HP:0001659) | 1.93699144 |
93 | Round ear (HP:0100830) | 1.93601749 |
94 | Back pain (HP:0003418) | 1.92553974 |
95 | Cholelithiasis (HP:0001081) | 1.92476502 |
96 | Mild short stature (HP:0003502) | 1.92208176 |
97 | Ectopia lentis (HP:0001083) | 1.91986352 |
98 | Spastic diplegia (HP:0001264) | 1.91953782 |
99 | Insomnia (HP:0100785) | 1.91463924 |
100 | Aortic aneurysm (HP:0004942) | 1.91198458 |
101 | Hepatocellular carcinoma (HP:0001402) | 1.91105298 |
102 | Distal arthrogryposis (HP:0005684) | 1.90966903 |
103 | Spinal rigidity (HP:0003306) | 1.90112586 |
104 | Abnormal atrioventricular conduction (HP:0005150) | 1.89966881 |
105 | Abnormal gallbladder morphology (HP:0012437) | 1.89438708 |
106 | Spontaneous abortion (HP:0005268) | 1.88694468 |
107 | Foot dorsiflexor weakness (HP:0009027) | 1.88642071 |
108 | Abnormality of the calf musculature (HP:0001430) | 1.88165686 |
109 | Joint laxity (HP:0001388) | 1.87576713 |
110 | Blue sclerae (HP:0000592) | 1.87496174 |
111 | Abnormal delivery (HP:0001787) | 1.85827844 |
112 | Exercise-induced muscle cramps (HP:0003710) | 1.85617451 |
113 | Lower limb amyotrophy (HP:0007210) | 1.85143176 |
114 | Hip contracture (HP:0003273) | 1.84454706 |
115 | Ulnar deviation of the wrist (HP:0003049) | 1.84316135 |
116 | Lymphangioma (HP:0100764) | 1.83482904 |
117 | Stridor (HP:0010307) | 1.83436179 |
118 | Sudden death (HP:0001699) | 1.83235559 |
119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82736192 |
120 | Osteolytic defects of the hand bones (HP:0009699) | 1.82736192 |
121 | Generalized amyotrophy (HP:0003700) | 1.82715594 |
122 | Scapular winging (HP:0003691) | 1.82246807 |
123 | Upper limb amyotrophy (HP:0009129) | 1.82222060 |
124 | Distal upper limb amyotrophy (HP:0007149) | 1.82222060 |
125 | Cerebral inclusion bodies (HP:0100314) | 1.80078648 |
126 | Hemorrhage of the eye (HP:0011885) | 1.78874668 |
127 | Spondylolisthesis (HP:0003302) | 1.78358672 |
128 | Hyperacusis (HP:0010780) | 1.78212388 |
129 | Abnormality of the foot musculature (HP:0001436) | 1.77834614 |
130 | Slender build (HP:0001533) | 1.77098556 |
131 | Supranuclear gaze palsy (HP:0000605) | 1.76987049 |
132 | Wrist flexion contracture (HP:0001239) | 1.76520948 |
133 | Camptodactyly of toe (HP:0001836) | 1.75496046 |
134 | Calcaneovalgus deformity (HP:0001848) | 1.75468743 |
135 | Abnormal cartilage morphology (HP:0002763) | 1.74822977 |
136 | Ankle clonus (HP:0011448) | 1.74218280 |
137 | Follicular hyperkeratosis (HP:0007502) | 1.73995141 |
138 | Aneurysm (HP:0002617) | 1.73852299 |
139 | Limb-girdle muscle weakness (HP:0003325) | 1.73753595 |
140 | Axonal loss (HP:0003447) | 1.73727732 |
141 | Heart block (HP:0012722) | 1.73066326 |
142 | Vascular calcification (HP:0004934) | 1.72998029 |
143 | Pulmonary artery stenosis (HP:0004415) | 1.72896559 |
144 | Lipoatrophy (HP:0100578) | 1.70574046 |
145 | Dilatation of the ascending aorta (HP:0005111) | 1.69972814 |
146 | Wide anterior fontanel (HP:0000260) | 1.68809424 |
147 | Soft skin (HP:0000977) | 1.68195742 |
148 | Overgrowth (HP:0001548) | 1.66815631 |
149 | Biconcave vertebral bodies (HP:0004586) | 1.66463544 |
150 | Torticollis (HP:0000473) | 1.65597990 |
151 | Hyperbilirubinemia (HP:0002904) | 1.65558591 |
152 | Abnormality of proline metabolism (HP:0010907) | 1.64920331 |
153 | Hydroxyprolinuria (HP:0003080) | 1.64920331 |
154 | Muscle fiber splitting (HP:0003555) | 1.64604050 |
155 | Striae distensae (HP:0001065) | 1.64525177 |
156 | Neonatal onset (HP:0003623) | 1.63890568 |
157 | Hyperextensible skin (HP:0000974) | 1.61458783 |
158 | Action tremor (HP:0002345) | 1.60060298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.18298654 |
2 | SIK1 | 3.79313807 |
3 | MYLK | 2.71962137 |
4 | BCKDK | 2.62742493 |
5 | PDGFRA | 2.54155908 |
6 | MARK1 | 2.54110119 |
7 | PKN2 | 2.47182159 |
8 | ERN1 | 2.46947566 |
9 | TTN | 2.31709789 |
10 | DDR2 | 2.23921531 |
11 | NTRK3 | 2.04212420 |
12 | EPHB1 | 1.93255628 |
13 | FGFR4 | 1.92728476 |
14 | CAMK1D | 1.92483149 |
15 | RIPK1 | 1.89245912 |
16 | LATS1 | 1.83984593 |
17 | FGFR2 | 1.79643432 |
18 | CAMK1G | 1.76482379 |
19 | PHKG1 | 1.72428680 |
20 | PHKG2 | 1.72428680 |
21 | PRPF4B | 1.65628783 |
22 | LATS2 | 1.53253561 |
23 | DMPK | 1.50581047 |
24 | UHMK1 | 1.46291042 |
25 | PTK6 | 1.45732152 |
26 | BMX | 1.44739499 |
27 | PRKD3 | 1.40767834 |
28 | PAK6 | 1.40435156 |
29 | LMTK2 | 1.35961134 |
30 | TESK1 | 1.34345838 |
31 | NTRK1 | 1.34242372 |
32 | LIMK1 | 1.33222755 |
33 | ERBB4 | 1.27587252 |
34 | MAP2K4 | 1.22973702 |
35 | ARAF | 1.18028306 |
36 | MAP3K7 | 1.15484633 |
37 | MET | 1.15161865 |
38 | PAK3 | 1.13643310 |
39 | RET | 1.09654472 |
40 | TYRO3 | 1.09232234 |
41 | CAMKK1 | 1.08893589 |
42 | CAMK1 | 1.08658293 |
43 | GRK5 | 1.08148658 |
44 | PIK3CA | 1.06440129 |
45 | PRKCH | 1.05893460 |
46 | CAMK2B | 1.04946080 |
47 | ICK | 1.03517310 |
48 | PDGFRB | 0.99711390 |
49 | PRKD1 | 0.99394525 |
50 | CDC42BPA | 0.99117543 |
51 | EPHA3 | 0.98193580 |
52 | PAK2 | 0.97926423 |
53 | KSR2 | 0.94974678 |
54 | EEF2K | 0.93358713 |
55 | PTK2 | 0.93285003 |
56 | TGFBR2 | 0.91898488 |
57 | DAPK2 | 0.90209852 |
58 | FER | 0.86186519 |
59 | PRKAA2 | 0.86175917 |
60 | EPHA4 | 0.85898803 |
61 | PIK3CG | 0.85061946 |
62 | WNK1 | 0.84288400 |
63 | PINK1 | 0.84255312 |
64 | ROCK2 | 0.84025186 |
65 | NEK9 | 0.82444870 |
66 | ROCK1 | 0.81830664 |
67 | OBSCN | 0.81682075 |
68 | FGFR1 | 0.81471721 |
69 | MAPK12 | 0.80785474 |
70 | PKN1 | 0.79278475 |
71 | EPHB2 | 0.78501348 |
72 | MOS | 0.76355769 |
73 | SGK3 | 0.76212926 |
74 | MAPK11 | 0.75325822 |
75 | PTK2B | 0.73894236 |
76 | AKT3 | 0.73876949 |
77 | STK38 | 0.73487812 |
78 | MTOR | 0.73456845 |
79 | JAK1 | 0.70008573 |
80 | CDK5 | 0.69722507 |
81 | SGK2 | 0.69283859 |
82 | TIE1 | 0.68862965 |
83 | CAMK2G | 0.68739001 |
84 | SGK223 | 0.68706028 |
85 | SGK494 | 0.68706028 |
86 | PDPK1 | 0.66991328 |
87 | GSK3A | 0.66677473 |
88 | MAPK4 | 0.66650261 |
89 | ERBB2 | 0.66334133 |
90 | RPS6KA2 | 0.66177458 |
91 | MAP3K6 | 0.65701794 |
92 | ILK | 0.63250792 |
93 | MAP3K13 | 0.61254849 |
94 | MINK1 | 0.60843522 |
95 | LRRK2 | 0.60252456 |
96 | MAPK10 | 0.59558820 |
97 | MAP2K1 | 0.59423644 |
98 | DYRK1B | 0.56785439 |
99 | CAMK2A | 0.55811163 |
100 | CDK6 | 0.55196290 |
101 | MST1R | 0.54961984 |
102 | PDK3 | 0.54622813 |
103 | PDK4 | 0.54622813 |
104 | INSRR | 0.53662930 |
105 | MAPKAPK5 | 0.53586846 |
106 | FGFR3 | 0.53192763 |
107 | ABL2 | 0.52774358 |
108 | STK39 | 0.52662827 |
109 | MAP3K10 | 0.52192631 |
110 | NTRK2 | 0.50346150 |
111 | CDK15 | 0.49709134 |
112 | MAPK7 | 0.49085636 |
113 | PRKCZ | 0.48115304 |
114 | PRKG2 | 0.47963129 |
115 | PRKAA1 | 0.46565804 |
116 | PRKACG | 0.46227526 |
117 | TAOK1 | 0.45717617 |
118 | JAK2 | 0.45061231 |
119 | TRPM7 | 0.44542802 |
120 | CDK11A | 0.44044230 |
121 | PRKG1 | 0.43778266 |
122 | MAPKAPK3 | 0.43737644 |
123 | CAMK4 | 0.43670819 |
124 | MARK2 | 0.43277027 |
125 | CDK18 | 0.43222319 |
126 | PLK2 | 0.43070047 |
127 | DAPK3 | 0.42580029 |
128 | SRC | 0.41756655 |
129 | PRKD2 | 0.40225732 |
130 | CAMK2D | 0.39130583 |
131 | PDK1 | 0.37748680 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.18271353 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.59830154 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.84548932 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83860936 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77957685 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45151129 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.40567914 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35113518 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27467664 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27338936 |
11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.15908545 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12650750 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11626399 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07517110 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07338332 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95593183 |
17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75490801 |
18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68875706 |
19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.64007305 |
20 | Bile secretion_Homo sapiens_hsa04976 | 1.58730172 |
21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51330408 |
22 | Peroxisome_Homo sapiens_hsa04146 | 1.50942051 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50630601 |
24 | Insulin secretion_Homo sapiens_hsa04911 | 1.42354207 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42144642 |
26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.41567543 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40361213 |
28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40042900 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38884325 |
30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38738177 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37310535 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.32705757 |
33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.31943277 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30820358 |
35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.30771383 |
36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29488046 |
37 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.28066079 |
38 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.27605052 |
39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24886597 |
40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24775359 |
41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24706836 |
42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.21111137 |
43 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.18907564 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16995144 |
45 | Gap junction_Homo sapiens_hsa04540 | 1.16220886 |
46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14473191 |
47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14301770 |
48 | Melanogenesis_Homo sapiens_hsa04916 | 1.13292720 |
49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12597721 |
50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10708890 |
51 | Morphine addiction_Homo sapiens_hsa05032 | 1.10250921 |
52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.07767530 |
53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07244665 |
54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06454132 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04556956 |
56 | Salivary secretion_Homo sapiens_hsa04970 | 1.04478076 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01720326 |
58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01462106 |
59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01256523 |
60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98758120 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98623424 |
62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97902819 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93829677 |
64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92411896 |
65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91337593 |
66 | Lysine degradation_Homo sapiens_hsa00310 | 0.90067657 |
67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89986929 |
68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87973259 |
69 | Axon guidance_Homo sapiens_hsa04360 | 0.86394793 |
70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85329096 |
71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84381605 |
72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84376347 |
73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83908724 |
74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83887106 |
75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83853985 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.83025427 |
77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81645376 |
78 | Nicotine addiction_Homo sapiens_hsa05033 | 0.81632210 |
79 | Adherens junction_Homo sapiens_hsa04520 | 0.81597124 |
80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81495770 |
81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80258899 |
82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76696576 |
83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74678733 |
84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73653825 |
85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73105321 |
86 | Tight junction_Homo sapiens_hsa04530 | 0.72225514 |
87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71755489 |
88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69270262 |
89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.69058732 |
90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68351012 |
91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66777214 |
92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66545626 |
93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66044467 |
94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.65514547 |
95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65196298 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65031406 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64937912 |
98 | Prion diseases_Homo sapiens_hsa05020 | 0.64932578 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64912276 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64395667 |
101 | Melanoma_Homo sapiens_hsa05218 | 0.63896656 |
102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62238236 |
103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60940542 |
104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60073355 |
105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59721998 |
106 | Long-term depression_Homo sapiens_hsa04730 | 0.59721018 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59649809 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.57658369 |
109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57310890 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.57013200 |
111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55429426 |
112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54804089 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54345411 |
114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53543952 |
115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53030457 |
116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52874823 |
117 | Focal adhesion_Homo sapiens_hsa04510 | 0.49672951 |
118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48955243 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44893272 |
120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42136187 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41492204 |
122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39672191 |
123 | Amoebiasis_Homo sapiens_hsa05146 | 0.38088161 |
124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37532250 |
125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37091364 |
126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32598893 |
127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30800134 |
128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30727060 |
129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27019860 |
130 | Glioma_Homo sapiens_hsa05214 | 0.25897091 |
131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24386392 |
132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23903315 |
133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23614613 |
134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23253148 |
135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23024457 |
136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22354612 |
137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21530355 |
138 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20163010 |
139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20067539 |
140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20007808 |
141 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19416760 |
142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.17205401 |
143 | Bladder cancer_Homo sapiens_hsa05219 | 0.16259158 |
144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15134625 |
145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14837410 |
146 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14604912 |
147 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13923677 |
148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.13737158 |
149 | Renin secretion_Homo sapiens_hsa04924 | 0.13675918 |
150 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13393216 |
151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13144813 |
152 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.12854393 |
153 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12611738 |
154 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11896938 |